A phase ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer

  • Yen Shen Lu
  • , Keun Seok Lee
  • , Tsu Yi Chao
  • , Ling Ming Tseng
  • , Imjai Chitapanarux
  • , Shin Cheh Chen
  • , Chien Ting Liu
  • , Joohyuk Sohn
  • , Jee Hyun Kim
  • , Yuan Ching Chang
  • , Youngsen Yang
  • , Kanjana Shotelersuk
  • , Kyung Hae Jung
  • , Roberta Valenti
  • , Cassandra Slader
  • , Melissa Gao
  • , Yeon Hee Park

研究成果: 雜誌貢獻文章同行評審

26 引文 斯高帕斯(Scopus)

指紋

深入研究「A phase ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer」主題。共同形成了獨特的指紋。

Pharmacology, Toxicology and Pharmaceutical Science